Literature DB >> 29948889

Optimization of reconstruction and quantification of motion-corrected coronary PET-CT.

Mhairi K Doris1,2, Yuka Otaki2, Sandeep K Krishnan2, Jacek Kwiecinski1,2, Mathieu Rubeaux2, Adam Alessio3, Tinsu Pan4, Sebastien Cadet2, Damini Dey2, Marc R Dweck1, David E Newby1, Daniel S Berman2, Piotr J Slomka5,6.   

Abstract

BACKGROUND: Coronary PET shows promise in the detection of high-risk atherosclerosis, but there remains a need to optimize imaging and reconstruction techniques. We investigated the impact of reconstruction parameters and cardiac motion-correction in 18F Sodium Fluoride (18F-NaF) PET.
METHODS: Twenty-two patients underwent 18F-NaF PET within 22 days of an acute coronary syndrome. Optimal reconstruction parameters were determined in a subgroup of six patients. Motion-correction was performed on ECG-gated data of all patients with optimal reconstruction. Tracer uptake was quantified in culprit and reference lesions by computing signal-to-noise ratio (SNR) in diastolic, summed, and motion-corrected images.
RESULTS: Reconstruction using 24 subsets, 4 iterations, point-spread-function modelling, time of flight, and 5-mm post-filtering provided the highest median SNR (31.5) compared to 4 iterations 0-mm (22.5), 8 iterations 0-mm (21.1), and 8 iterations 5-mm (25.6; all P < .05). Motion-correction improved SNR of culprit lesions (n = 33) (24.5[19.9-31.5]) compared to diastolic (15.7[12.4-18.1]; P < .001) and summed data (22.1[18.9-29.2]; P < .001). Motion-correction increased the SNR difference between culprit and reference lesions (10.9[6.3-12.6]) compared to diastolic (6.2[3.6-10.3]; P = .001) and summed data (7.1 [4.8-11.6]; P = .001).
CONCLUSIONS: The number of iterations and extent of post-filtering has marked effects on coronary 18F-NaF PET quantification. Cardiac motion-correction improves discrimination between culprit and reference lesions.

Entities:  

Keywords:  Atherosclerosis; Cardiac motion; Computed tomography; Positron emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29948889      PMCID: PMC6289874          DOI: 10.1007/s12350-018-1317-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

1.  Understanding the standardized uptake value, its methods, and implications for usage.

Authors:  Joseph A Thie
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

2.  Symmetric log-domain diffeomorphic Registration: a demons-based approach.

Authors:  Tom Vercauteren; Xavier Pennec; Aymeric Perchant; Nicholas Ayache
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

3.  Clinical Relevance of 18F-Sodium Fluoride Positron-Emission Tomography in Noninvasive Identification of High-Risk Plaque in Patients With Coronary Artery Disease.

Authors:  Joo Myung Lee; Ji-In Bang; Bon-Kwon Koo; Doyeon Hwang; Jonghanne Park; Jinlong Zhang; Tong Yaliang; Minseok Suh; Jin Chul Paeng; Yasutsugu Shiono; Takashi Kubo; Takashi Akasaka
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

4.  18F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis.

Authors:  Toshiro Kitagawa; Hideya Yamamoto; Shinya Toshimitsu; Ko Sasaki; Atsuhiro Senoo; Yumiko Kubo; Fuminari Tatsugami; Kazuo Awai; Yutaka Hirokawa; Yasuki Kihara
Journal:  Atherosclerosis       Date:  2017-04-29       Impact factor: 5.162

5.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

Authors:  Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

6.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

7.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

8.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

9.  Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques.

Authors:  Mathieu Rubeaux; Nikhil V Joshi; Marc R Dweck; Alison Fletcher; Manish Motwani; Louise E Thomson; Guido Germano; Damini Dey; Debiao Li; Daniel S Berman; David E Newby; Piotr J Slomka
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

10.  Data on analysis of coronary atherosclerosis on computed tomography and 18F-sodium fluoride positron emission tomography.

Authors:  Toshiro Kitagawa; Hideya Yamamoto; Shinya Toshimitsu; Ko Sasaki; Atsuhiro Senoo; Yumiko Kubo; Fuminari Tatsugami; Kazuo Awai; Yutaka Hirokawa; Yasuki Kihara
Journal:  Data Brief       Date:  2017-06-12
View more
  24 in total

1.  Aortic 18F-sodium fluoride imaging.

Authors:  Jacek Kwiecinski; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2021-04-06       Impact factor: 5.952

2.  Hype or Hope18F-NaF Positron Emission Tomography for Vulnerable Coronary Plaque Imaging.

Authors:  Mani Salarian; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2019-08-06       Impact factor: 7.792

3.  Peri-Coronary Adipose Tissue Density Is Associated With 18F-Sodium Fluoride Coronary Uptake in Stable Patients With High-Risk Plaques.

Authors:  Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Sang-Eun Lee; Yuka Otaki; Phi T Huynh; Mhairi K Doris; Evann Eisenberg; Mijin Yun; Maurits A Jansen; Michelle C Williams; Balaji K Tamarappoo; John D Friedman; Marc R Dweck; David E Newby; Hyuk-Jae Chang; Piotr J Slomka; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2019-02-13

4.  Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography.

Authors:  Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Sang-Eun Lee; Balaji Tamarappoo; Yuka Otaki; Phi T Huynh; John D Friedman; Mark R Dweck; David E Newby; Mijin Yun; Hyuk-Jae Chang; Piotr J Slomka; Daniel S Berman
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-01-01       Impact factor: 6.875

Review 5.  Vulnerable plaque imaging using 18F-sodium fluoride positron emission tomography.

Authors:  Jacek Kwiecinski; Piotr J Slomka; Marc R Dweck; David E Newby; Daniel S Berman
Journal:  Br J Radiol       Date:  2019-12-19       Impact factor: 3.039

6.  Feasibility of Coronary 18F-Sodium Fluoride Positron-Emission Tomography Assessment With the Utilization of Previously Acquired Computed Tomography Angiography.

Authors:  Jacek Kwiecinski; Philip D Adamson; Martin L Lassen; Mhairi K Doris; Alastair J Moss; Sebastian Cadet; Maurits A Jansen; Damini Dey; Sang-Eun Lee; Mijin Yun; Hyuk-Jae Chang; Marc R Dweck; David E Newby; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2018-12       Impact factor: 7.792

7.  Analytical quantification of aortic valve 18F-sodium fluoride PET uptake.

Authors:  Daniele Massera; Mhairi K Doris; Sebastien Cadet; Jacek Kwiecinski; Tania A Pawade; Frederique E C M Peeters; Damini Dey; David E Newby; Marc R Dweck; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2018-11-29       Impact factor: 5.952

8.  Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET.

Authors:  Martin Lyngby Lassen; Jacek Kwiecinski; Damini Dey; Sebastien Cadet; Guido Germano; Daniel S Berman; Philip D Adamson; Alastair J Moss; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-05       Impact factor: 9.236

9.  Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden.

Authors:  Jacek Kwiecinski; Sebastien Cadet; Marwa Daghem; Martin L Lassen; Damini Dey; Marc R Dweck; Daniel S Berman; David E Newby; Piotr J Slomka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

10.  Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.

Authors:  Evangelos Tzolos; Jacek Kwiecinski; Martin Lyngby Lassen; Sebastien Cadet; Philip D Adamson; Alastair J Moss; Nikhil Joshi; Michelle C Williams; Edwin J R van Beek; Damini Dey; Daniel S Berman; Marc R Dweck; David E Newby; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2020-06-11       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.